$WTMA
Welsbach Technology Metals Acquisition Corp

2023 Q4 Form 10-Q Financial Statement

#000121390023088715 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $328.5K $605.5K $1.113M
YoY Change -75.27% -45.57%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $328.5K $605.5K $1.113M
YoY Change -75.27% -45.57% 3708423.33%
Operating Profit -$605.5K -$1.113M
YoY Change -45.57%
Interest Expense $313.6K $507.9K $349.0K
YoY Change -52.49% 45.53%
% of Operating Profit
Other Income/Expense, Net $507.9K $349.0K
YoY Change 45.53%
Pretax Income -$14.94K -$97.62K -$763.6K
YoY Change -97.77% -87.22%
Income Tax $0.00 -$261.9K $52.58K
% Of Pretax Income
Net Earnings -$14.94K $164.3K -$816.1K
YoY Change -98.12% -120.13% 2720343.33%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.03 -$0.08
COMMON SHARES
Basic Shares Outstanding 4.457M shares 5.914M shares 10.01M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.760K $94.58K $436.4K
YoY Change -97.82% -78.33%
Cash & Equivalents $6.760K $94.58K $436.4K
Short-Term Investments
Other Short-Term Assets $830.00 $42.12K $12.42K
YoY Change -96.68% 239.13%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.593K $136.7K $448.8K
YoY Change -97.73% -69.54%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $5.000M $5.000M $5.000M
YoY Change 0.0% 0.0%
Long-Term Investments $23.77M $39.61M $78.51M
YoY Change -70.16% -49.54%
Other Assets $161.5K $213.2K
YoY Change -24.27%
Total Long-Term Assets $23.93M $39.83M $78.51M
YoY Change -70.03% -49.27%
TOTAL ASSETS
Total Short-Term Assets $7.593K $136.7K $448.8K
Total Long-Term Assets $23.93M $39.83M $78.51M
Total Assets $23.94M $39.96M $78.96M
YoY Change -70.15% -49.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.846M $2.792M $727.7K
YoY Change 56.5% 283.65%
Accrued Expenses $80.00K $336.2K $131.4K
YoY Change -51.03% 155.85%
Deferred Revenue
YoY Change
Short-Term Debt $2.845M $2.780M $772.8K
YoY Change 84.11% 259.81%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.649M $22.66M $1.884M
YoY Change 69.88% 1102.98%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.705M $2.705M $2.705M
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $2.705M $2.705M $2.705M
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.649M $22.66M $1.884M
Total Long-Term Liabilities $2.705M $2.705M $2.705M
Total Liabilities $9.353M $25.36M $4.588M
YoY Change 41.32% 452.8%
SHAREHOLDERS EQUITY
Retained Earnings -$9.266M -$8.988M -$3.889M
YoY Change 56.0% 131.1%
Common Stock $228.00 $228.00 $228.00
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$9.266M -$8.987M -$3.889M
YoY Change
Total Liabilities & Shareholders Equity $23.94M $39.96M $78.96M
YoY Change -70.15% -49.39%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$14.94K $164.3K -$816.1K
YoY Change -98.12% -120.13% 2720343.33%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$647.2K -$350.2K -$354.8K
YoY Change 205.68% -1.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $16.16M -$153.4K -$772.8K
YoY Change -3506.34% -80.15%
Cash From Investing Activities $16.16M -$153.4K -$772.8K
YoY Change -3506.34% -80.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.65M 738.3K 772.8K
YoY Change -2125.23% -4.46%
NET CHANGE
Cash From Operating Activities -647.2K -350.2K -354.8K
Cash From Investing Activities 16.16M -153.4K -772.8K
Cash From Financing Activities -15.65M 738.3K 772.8K
Net Change In Cash -139.5K 234.7K -354.8K
YoY Change -260.93% -166.15%
FREE CASH FLOW
Cash From Operating Activities -$647.2K -$350.2K -$354.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41183
dei Entity Registrant Name
EntityRegistrantName
Welsbach Technology Metals Acquisition Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-1006702
dei Entity Address Address Line1
EntityAddressAddressLine1
160 S Craig Place
dei Entity Address City Or Town
EntityAddressCityOrTown
Lombard
dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60148
dei City Area Code
CityAreaCode
(217)
dei Local Phone Number
LocalPhoneNumber
615-1216
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4456827 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94579 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
309881 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
42121 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
136700 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
334881 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
213182 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
213182 usd
CY2023Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
39613658 usd
CY2022Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
79645156 usd
CY2023Q3 us-gaap Assets
Assets
39963540 usd
CY2022Q4 us-gaap Assets
Assets
80193219 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2791734 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1818627 usd
CY2023Q3 wtma Due To Affiliate
DueToAffiliate
263663 usd
CY2022Q4 wtma Due To Affiliate
DueToAffiliate
205663 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
336155 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
163384 usd
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
188177 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
180688 usd
CY2023Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
583520 usd
CY2023Q3 wtma Due To Shareholders For Redemption Of Common Stock
DueToShareholdersForRedemptionOfCommonStock
15715387 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2780471 usd
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1545537 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
22659107 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3913899 usd
CY2023Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2704690 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
2704690 usd
CY2023Q3 us-gaap Liabilities
Liabilities
25363797 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6618589 usd
CY2023Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2172851 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
7727686 shares
CY2023Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.86
CY2022Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.29
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
23587121 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
79514266 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2283976 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2283976 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2283976 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2283976 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
228 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
228 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8987606 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5939864 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-8987378 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5939636 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39963540 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80193219 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
555524 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1062557 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1744482 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1852616 usd
CY2023Q3 us-gaap Other General Expense
OtherGeneralExpense
50000 usd
CY2022Q3 us-gaap Other General Expense
OtherGeneralExpense
50000 usd
us-gaap Other General Expense
OtherGeneralExpense
150000 usd
us-gaap Other General Expense
OtherGeneralExpense
150000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-605524 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1112557 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1894482 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2002616 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
507906 usd
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
349006 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1855102 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
461130 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
507906 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
349006 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1855102 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
461130 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-97618 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-763551 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-39380 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1541486 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-261911 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52582 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52582 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
164293 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-816133 usd
us-gaap Net Income Loss
NetIncomeLoss
-39380 usd
us-gaap Net Income Loss
NetIncomeLoss
-1594068 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5939636 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
750670 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-230201 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-6920507 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
722985 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
26528 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-7616964 usd
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
951187 usd
CY2023Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
583520 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
164293 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-8987378 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1231823 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
45540 usd
CY2022Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
73142 usd
CY2022Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
198370 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-569282 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1880793 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-208653 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2089446 usd
CY2022Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
983176 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-816133 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3888755 usd
us-gaap Net Income Loss
NetIncomeLoss
-39380 usd
us-gaap Net Income Loss
NetIncomeLoss
-1594068 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
1855102 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
461133 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
17121 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-320216 usd
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
58000 usd
us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
119490 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
973107 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
727668 usd
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
172771 usd
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
70642 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7489 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
52582 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-700236 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-764603 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
750000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
3049628 usd
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
124166 usd
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
124166 usd
us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
42636600 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
41886600 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3049628 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2276860 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
45540 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
45538 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-42636600 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
1234934 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
772769 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-41401666 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3049631 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-215302 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-764600 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523063 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1200956 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
307761 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
436356 usd
CY2023Q3 us-gaap Cash
Cash
94579 usd
CY2022Q3 us-gaap Cash
Cash
436356 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
213182 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
307761 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
436356 usd
wtma Deferred Underwriting Commission Payable
DeferredUnderwritingCommissionPayable
79690 usd
wtma Accretion For Redeemable Common Stock To Redemption Value
AccretionForRedeemableCommonStockToRedemptionValue
2424842 usd
us-gaap Stock Issued1
StockIssued1
583520 usd
CY2023Q3 wtma Due To Shareholders For Redemption Of Common Stock
DueToShareholdersForRedemptionOfCommonStock
15715387 usd
CY2021Q4 us-gaap Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
75000000 usd
CY2023Q3 us-gaap Shares Issued
SharesIssued
347500 shares
us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
1125000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.50 pure
CY2023Q3 us-gaap Share Price
SharePrice
10
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5000001 usd
wtma Common Stock Percentage
CommonStockPercentage
0.20 pure
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
1 pure
wtma Dissolution Expenses
DissolutionExpenses
100000 usd
CY2022Q3 us-gaap Deposits
Deposits
772769 usd
CY2022Q4 us-gaap Deposits
Deposits
772769 usd
CY2023Q1 us-gaap Payments For Deposits
PaymentsForDeposits
125000 usd
CY2023Q1 us-gaap Share Price
SharePrice
10
CY2023Q1 us-gaap Deposits
Deposits
125000 usd
CY2023Q2 us-gaap Deposits
Deposits
125000 usd
CY2023Q2 us-gaap Deposits
Deposits
125000 usd
CY2023Q2 us-gaap Deposits
Deposits
125000 usd
CY2023Q3 us-gaap Deposits
Deposits
125000 usd
CY2023Q3 us-gaap Deposits
Deposits
125000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4097964 shares
CY2023Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.4
CY2023Q1 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
42600000 usd
CY2023Q2 wtma Shares Exercising Price
SharesExercisingPrice
42636600 usd
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1456871 shares
CY2023Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.79
CY2023Q3 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
15700000 usd
CY2023Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
23400000 usd
CY2022Q3 wtma Effective Incomes Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomesTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.01 pure
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.01 pure
CY2023Q1 wtma Stockholders Redeemed Common Shares
stockholdersRedeemedCommonShares
4097964 shares
CY2023Q3 wtma Stockholders Redeemed Common Shares
stockholdersRedeemedCommonShares
1456871 shares
CY2023Q1 us-gaap Payable Common Stock Redeemed
PayableCommonStockRedeemed
42636600 usd
CY2023Q3 us-gaap Payable Common Stock Redeemed
PayableCommonStockRedeemed
15715837 usd
CY2023Q1 wtma Effective Incomes Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomesTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.01 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.01 pure
CY2023Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
583520 usd
CY2023Q3 us-gaap Cash
Cash
94579 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
213182 usd
CY2023Q3 wtma Working Capital Amount
WorkingCapitalAmount
6807020 usd
wtma Financial Term
FinancialTerm
P1Y
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements. Making estimates requires management to exercise significant judgment. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from those estimates.</p>
us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
42636600 usd
CY2022Q4 wtma Franchise Taxes
FranchiseTaxes
85232 usd
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
213182 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
142851 usd
CY2022 wtma Balance Amosunt
BalanceAmosunt
213182 usd
wtma Balance Amosunt
BalanceAmosunt
213182 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Concentration of Credit Risk</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit. As of September 30, 2023, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.</p>
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-2.683 pure
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0689 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0341 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
4097964 shares
CY2023Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.4
CY2023Q1 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
80400000 usd
CY2023Q2 us-gaap Payable Common Stock Redeemed
PayableCommonStockRedeemed
42636600 usd
CY2023Q3 us-gaap Shares Issued
SharesIssued
1456871 shares
CY2023Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.79
CY2023Q3 wtma Aggregate Redemption Amount
AggregateRedemptionAmount
15700000 usd
CY2023Q3 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
23400000 usd
CY2023Q3 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
39600000 usd
CY2023Q3 wtma Trust Account
TrustAccount
23400000 usd
CY2023Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
39600000 usd
us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
79514266 usd
CY2022 us-gaap Sale Leaseback Transaction Net Proceeds Financing Activities
SaleLeasebackTransactionNetProceedsFinancingActivities
77276860 usd
CY2022 wtma Fair Value Of Public Rights At Issuance
FairValueOfPublicRightsAtIssuance
2627413 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4626437 usd
us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
-58351987 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2424842 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
9491256 usd
CY2023Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
23587121 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
79514266 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4097964 shares
CY2023Q1 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.4
CY2023Q1 wtma Aggregate Redemption Amount
AggregateRedemptionAmount
42600000 usd
CY2023Q1 wtma Trust Account
TrustAccount
37800000 usd
CY2023Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
80400000 usd
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1456871 shares
CY2023Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.79
CY2023Q3 wtma Aggregate Redemption Amount
AggregateRedemptionAmount
15700000 usd
CY2022Q1 wtma Aggregate Purchase Price
AggregatePurchasePrice
45540 usd
CY2022Q1 wtma Forfeited Shares
ForfeitedShares
224328 shares
wtma Limited Exception
LimitedException
0.50 pure
CY2022Q1 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
259136 usd
CY2023Q3 us-gaap Business Acquisition Preacquisition Contingency Amount Of Settlement
BusinessAcquisitionPreacquisitionContingencyAmountOfSettlement
263663 usd
CY2022Q4 us-gaap Financing Receivable Revolving
FinancingReceivableRevolving
205663 usd
wtma Working Capital Loans
WorkingCapitalLoans
1500000 usd
CY2023Q3 wtma Principal Amount Of Sponsor
PrincipalAmountOfSponsor
84000 usd
CY2023Q3 wtma Principal Amount Of Sponsor
PrincipalAmountOfSponsor
378000 usd
CY2023Q3 wtma Principal Amount Of Sponsor
PrincipalAmountOfSponsor
22000 usd
CY2023Q3 wtma Price Per Share
PricePerShare
10
wtma Working Capital Loans
WorkingCapitalLoans
1500000 usd
wtma Balance Outstanding Working Capital Notes
BalanceOutstandingWorkingCapitalNotes
484100 usd
CY2022 wtma Balance Outstanding Working Capital Notes
BalanceOutstandingWorkingCapitalNotes
0 usd
CY2022Q3 wtma Principal Amount Of Sponsor
PrincipalAmountOfSponsor
772769 usd
CY2022Q3 wtma Business Combination Into Additional Private Units
BusinessCombinationIntoAdditionalPrivateUnits
10 usd
CY2022Q4 wtma Principal Amount Of Sponsor
PrincipalAmountOfSponsor
772769 usd
CY2022Q4 wtma Business Combination Into Additional Private Units
BusinessCombinationIntoAdditionalPrivateUnits
10 usd
CY2023Q1 wtma Principal Amount Of Sponsor
PrincipalAmountOfSponsor
125000 usd
CY2023Q1 wtma Business Combination Into Additional Private Units
BusinessCombinationIntoAdditionalPrivateUnits
10 usd
wtma Post Business Combination Price Per Unit
PostBusinessCombinationPricePerUnit
10
wtma Balance Outstanding Promisorry Note
BalanceOutstandingPromisorryNote
2296371 usd
CY2022 wtma Balance Outstanding Promisorry Note
BalanceOutstandingPromisorryNote
1545537 usd
CY2023Q2 wtma Principal Amount
PrincipalAmount
125000 usd
CY2023Q2 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
124166 usd
CY2023Q2 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
25000 usd
CY2023Q3 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
99166 usd
CY2021Q4 us-gaap Sponsor Fees
SponsorFees
10000 usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
30000 usd
CY2022Q3 us-gaap Other Expenses
OtherExpenses
30000 usd
us-gaap Other Expenses
OtherExpenses
90000 usd
wtma Underwriting Discount
UnderwritingDiscount
0.2
wtma Aggregate Underwriting Fee
AggregateUnderwritingFee
1545537 usd
wtma Additional Underwriting Payable Per Share
AdditionalUnderwritingPayablePerShare
0.35
CY2023Q3 us-gaap Other Loans Payable
OtherLoansPayable
2704690 usd
CY2023Q3 us-gaap Net Shares Reclassified To Mandatorily Redeemable Capital Stock Shares
NetSharesReclassifiedToMandatorilyRedeemableCapitalStockShares
2432185 shares
CY2023Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
25000000 usd
CY2023Q3 us-gaap Shares Issued
SharesIssued
500000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100000 shares
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2283976 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2283976 shares
CY2023Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2172851 shares
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
7727686 shares
CY2023Q3 wtma Company Withdrew Amount
CompanyWithdrewAmount
42636600 usd
CY2023Q3 us-gaap Other Interest Earning Assets
OtherInterestEarningAssets
837367 usd
CY2023Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
298414 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
213182 usd
CY2023Q4 us-gaap Temporary Equity Aggregate Amount Of Redemption Requirement
TemporaryEquityAggregateAmountOfRedemptionRequirement
15715387 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
554273 usd
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
usd
CY2022Q4 wtma Due To Shareholders For Redemption Of Common Stock
DueToShareholdersForRedemptionOfCommonStock
usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
usd
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
usd
us-gaap Proceeds From Decommissioning Fund
ProceedsFromDecommissioningFund
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022Q3 us-gaap Restricted Cash
RestrictedCash
usd
wtma Deferred Underwriting Commission Payable
DeferredUnderwritingCommissionPayable
usd
wtma Accretion For Redeemable Common Stock To Redemption Value
AccretionForRedeemableCommonStockToRedemptionValue
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2022Q3 wtma Due To Shareholders For Redemption Of Common Stock
DueToShareholdersForRedemptionOfCommonStock
usd
wtma Fair Value Of Public Rights At Issuance
FairValueOfPublicRightsAtIssuance
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
CY2022 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001866226

Files In Submission

Name View Source Status
wtma-20230930_def.xml Edgar Link unprocessable
wtma-20230930_pre.xml Edgar Link unprocessable
0001213900-23-088715-index-headers.html Edgar Link pending
0001213900-23-088715-index.html Edgar Link pending
0001213900-23-088715.txt Edgar Link pending
0001213900-23-088715-xbrl.zip Edgar Link pending
f10q0923ex31-1_welsbachtech.htm Edgar Link pending
f10q0923ex31-2_welsbachtech.htm Edgar Link pending
f10q0923ex32-1_welsbachtech.htm Edgar Link pending
f10q0923ex32-2_welsbachtech.htm Edgar Link pending
f10q0923_welsbachtech.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10q0923_welsbachtech_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wtma-20230930.xsd Edgar Link pending
wtma-20230930_cal.xml Edgar Link unprocessable
wtma-20230930_lab.xml Edgar Link unprocessable